Dopamine

This classification denotes a catecholamine with the molecular formula C8H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VTD58H1Z2X, chemically known as 3,4-dihydroxyphenylethylamine but generally known as dopamine, which bears US NIH Compound Identifier 681. European Medicines Agency schedules Dopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06365MIG. The term DOPAMINE is an International Non-Proprietary Name. World Health Organization schedules dopamine in its Anatomical Therapeutic Chemical (ATC) Classification. DOPAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dopamine under HS 29222900 and SITC 51462. As of Q4 2014, DOPAMINE remains the US FDA Preferred Term for this commodity. Dopamine bears US NLM identifiers UMLS ID C0013030 and NCI Concept Code C62025. SMILES: OC1CC(CCN)CCC1O.